Terrie Curran, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 17,374 shares at $10.85 ($189K) on 2024-11-11, disclosed to the SEC on 2024-11-13.
Open-market sale of $189k ARQT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.85 | 8,687 | $94K | 50.0% |
| 2 | $10.85 | 8,687 | $94K | 50.0% |
| Total | $10.85 avg | 17,374 | $189K | 100% |
| Filing → |
| PHAT | SELL | 2025-01-23 | $252K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $793K | — | Filing → |
| PHAT | SELL | 2024-03-26 | $307K | — | Filing → |